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Summary
The gene for autosomal recessive juvenile Parkinsonism
(AR-JP) recently has been mapped to chromosome
6q25.2–27 in Japanese families. We have tested one Al-
gerian and 10 European multiplex families with early-
onset Parkinson disease for linkage to this locus, with
marker D6S305. Homogeneity analysis provided a con-
ditional probability in favor of linkage of 1.9 in eight
families, which were analyzed further with eight micro-
satellite markers spanning the 17-cM AR-JP region.
Haplotype reconstruction for eight families and deter-
mination of the smallest region of homozygosity in two
consanguineous families reduced the candidate interval
to 11.3 cM. If the deletion of two microsatellite markers
(D6S411 and D6S1550) that colocalize on the genetic
map and that segregate with the disease in the Algerian
family is taken into account, the candidate region would
be reduced to !1 cM. These findings should facilitate
identification of the corresponding gene. We have con-
firmed linkage of AR-JP, in European families and in an
Algerian family, to the PARK2 locus. PARK2 appears to
be an important locus for AR-JP in European patients.
The clinical spectrum of the disease in our families, with
age at onset X58 years and the presence of painful dys-
tonia in some patients, is broader than that reported
previously.
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Introduction
Parkinson disease (PD), a frequent disorder with a life-
time risk of 2%, is characterized mainly by degeneration
of brain dopaminergic pathways. The main clinical fea-
tures are rigidity, bradykinesia, and tremor, with an in-
itial good response to levodopa (Agid 1991). Genetic
risk factors probably are involved in the pathogenesis
of the idiopathic form (Wood 1997), and several families
with clearly established monogenic inheritance have
been reported. An autosomal dominant type of PD has
been mapped to chromosome 4q (PD1) in a large Italian
kindred (Polymeropoulos et al. 1996) in which a mis-
sense mutation of the a-synuclein gene has been iden-
tified (Polymeropoulos et al. 1997). A different missense
mutation was detected in a German kindred (Kru¨ger et
al. 1998). It is probably, however, an uncommon locus
for familial PD (The French Parkinson’s Disease Genetics
Study Group 1998; Vaughan et al., in press). Another
locus for autosomal dominant PD recently has been
mapped to chromosome 2p13 (Gasser et al. 1998). An
autosomal recessive form of Parkinsonism (AR-JP [au-
tosomal recessive juvenile Parkinsonism]) has been de-
scribed in several Japanese families (Yamamura et al.
1973; Yamamura et al. 1993; Takahashi et al. 1994;
Ishikawa and Tsuji 1996) and recently has been mapped
to chromosome 6q25.2-27 (Matsumine et al. 1997).
This locus is also designated “PARK2” (MIM 600116).
The 17-cM interval defined by the study by Matsumine
et al. (1997) contains the Mn-superoxide dismutase gene
(SOD2), which was excluded as a candidate gene, by
sequence analysis of 13 patients. Prominent clinical fea-
tures are early onset, mostly at !40 years of age, Par-
kinsonism with rigidity, resting and/or postural tremor,
bradykinesia, postural instability, excellent response to
levodopa but with levodopa-induced dyskinesias and
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Table 1
Two-Point LOD Scores for D6S305 Marker in 11 Families with
Autosomal Recessive Early-Onset Parkinsonism
FAMILY
LOD SCORE AT v 
.00 .01 .05 .10 .20 .30 .40
IT-2-021 1.92 1.88 1.73 1.52 1.08 .61 .19
IT-1-005 1.56 1.52 1.38 1.20 .82 .45 .13
LYO-119 1.51 1.47 1.34 1.17 .82 .50 .21
DEL-001 1.15 1.12 1.01 .88 .61 .37 .15
IT-2-022 1.06 1.04 .93 .80 .53 .28 .08
SAL-711 1.00 .97 .87 .75 .50 .26 .07
GRE-017 .84 .82 .73 .62 .40 .20 .05
IT-1-006 .70 .68 .61 .51 .32 .16 .04
SAL-028 5.57 1.28 .61 .36 .14 .05 .01
IT-1-031 5.94 1.30 .63 .37 .15 .06 .01
SAL-727 11.38 2.69 1.36 .84 .37 .15 .04
wearing-off phenomenon associated with foot dystonia
and sleep benefit (Ishikawa and Tsuji 1996). Selective
neurodegeneration and gliosis were observed in the sub-
stantia nigra pars compacta, but Lewy bodies, the path-
ological hallmark of idiopathic PD, were not detected
in the few patients examined (Yamamura et al. 1993;
Takahashi et al. 1994). In order to determine if this
genetic entity was restricted to Japan, we performed link-
age analysis with markers from the PARK2 region in
one Algerian and 10 European multiplex families with
early-onset Parkinsonism compatible with autosomal re-
cessive inheritance.
Patients and Methods
Patients
Families were selected according to the following cri-
teria: (1) presence, in all examined patients, of two of
the three cardinal signs of PD (akinesia, rigidity, and
tremor); (2) marked improvement with levodopa treat-
ment, except in two untreated secondary cases; (3) age
at onset X40 years for at least one affected sib; and (4)
family history compatible with autosomal recessive in-
heritance—that is, with the presence of the disease in at
least two patients in a single generation and/or consan-
guinity. There were 11 families: five Italian (IT-1-005,
IT-1-006, IT-2-021, IT-2-022, and IT-1-031), four
French (GRE-017, SAL-028, LYO-119, and SAL-727),
one Portuguese (SAL-711), and one Algerian (DEL-001).
These families were selected from among 104 kindreds
comprising at least one affected sib pair fulfulling criteria
1 and 2. Blood samples were taken, with informed con-
sent, from 30 patients and from 22 clinically unaffected
first-degree relatives.
Genotypes
Genotypes were determined with either [32P]-labeled
primers (Stevanin et al. 1994) or fluorescent primers an-
alyzed on an ABI377 automated sequencer with the
GENESCAN and GENOTYPER software. The PCR
conditions were as described in the Genome Database
(GDB). All families were genotyped for microsatellite
D6S305. After linkage and HOMOG analysis, families
with a high posterior probability in favor of linkage were
genotyped for eight additional microsatellite markers
spanning the ∼17-cM PARK2 locus (Matsumine et al.
1997) on chromosome 6q: cen–D6S419–2.3 cM–
D6S1581–1.6 cM–D6S1579–0 cM–D6S411–0 cM–
D6S1550–0 cM–D6S305–3.6 cM–D6S1599–7.7 cM–
D6S1719–1.2 cM–D6S264–tel (Dib et al. 1996). Hap-
lotypes were reconstructed manually. The primers used
for analysis of SOD2 were those described in Genbank
(accession number X07834).
Linkage and Homogeneity Analysis
Linkage analysis was performed with the LINKAGE
and FASTLINK software packages (Lathrop et al. 1985;
Scha¨ffer et al. 1994), with the same parameters used by
Matsumine et al. (1997), except for the liability classes,
which were derived from the cumulative age-dependent
penetrance in our 11 families: class I, 0–25 years of age,
penetrance .0665; class II, 26–35 years of age, pene-
trance .3165; class III, 36–40 years of age, penetrance
.615; class IV, 41–50 years of age, penetrance .815; class
V, 150 years of age, penetrance .95. Allele frequencies
were derived from the GDB. Linkage homogeneity was
tested by use of the HOMOG program of Ott (1991),
with the two-point LOD scores obtained, for the 11
families, with marker D6S305.
Statistical Analysis
Means were compared by use of nonparametric tests,
and frequencies were compared by use of the x2 test,
with the Yates correction used when appropriate.
Results
Linkage Analysis
Linkage to PARK2 was first tested with marker
D6S305, in the 52 members of the 11 families, including
the 30 patients. Two-point LOD scores at a recombi-
nation fraction (v) of .00 were positive (range 0.70–1.92)
in 8 families and were negative over the entire tested
interval in the other 3 families (table 1). The odds, cal-
culated with the HOMOG program, in favor of linkage
with heterogeneity (H2) as opposed to no linkage (H0)
and to linkage and homogeneity (H1) were 1.1#
and 11.3:1, respectively. The conditional proba-710 :1
bility in favor of linkage to marker D6S305 was equal
to zero for the three families with negative LOD scores
at all tested values of v. In addition, negative scores at
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Table 2
Cumulative Pairwise LOD Scores between Nine Chromosome 6q
Markers and the PARK2 Locus in Eight Families
MARKER
LOD SCORE AT v 
Zmax vmax.00 .01 .05 .1 .2 .3 .4
D6S419 8.19 1.99 3.43 3.49 2.66 1.52 .48 3.54 .077
D6S1581 5.88 .67 1.66 1.75 1.32 .72 .21 1.76 .084
D6S1579 2.33 4.49 4.58 4.11 2.87 1.59 .50 4.66 .029
D6S411 2.39 1.55 1.98 1.89 1.35 .73 .22 1.98 .059
D6S1550 1.17 2.99 3.21 2.90 1.96 .98 .25 3.24 .036
D6S305 9.73 9.51 8.59 7.43 5.09 2.82 .94 9.73 .0
D6S1599 8.76 8.55 7.71 6.64 4.49 2.45 .80 8.76 .0
D6S1719 3.55 5.70 5.71 5.13 3.62 2.01 .63 5.84 .025
D6S264 7.50 .97 1.97 2.06 1.59 .93 .34 2.68 .073
NOTE.—Markers are ordered from centromere to telomere. Markers
D6S1579 and D6S305 were positioned on the basis of recombination
events determined by haplotype reconstruction (see fig. 1). Markers
D6S411 and D6S1550 were ordered arbitrarily.
all values of v tested with markers D6S419 and D6S264
also were obtained for these three families, supporting
the hypothesis that these families do not present evidence
for linkage to the PARK2 locus (data not shown). This
was confirmed by multipoint LOD scores computed for
markers D6S419, D6S305, and D6S264, which gener-
ated LOD scores below 1.20 for the entire candidate
interval in each of these families (data not shown). In
eight families for which the conditional probability in
favor of linkage was 1.9 (range .92–.99), eight other
microsatellite markers spanning the 17-cM AR-JP can-
didate region were genotyped. The maximum two-point
LOD scores for a marker within the PARK2 candidate
region were within the range 0.84–1.92, with a cumu-
lative maximum of 9.73 at D6S305 (table 2). The max-
imum multipoint LOD score calculated with data for
D6S419, D6S305, and D6S264 was 10.76 at D6S305.
Haplotype Reconstruction
Haplotypes were reconstructed for nine microsatellite
markers spanning 17 cM on chromosome 6q in the eight
families presenting evidence for linkage to the PARK2
locus (fig. 1). Recombination events were detected in
affected members of four families. In family IT-1-005,
a recombination event detected in patient 12 situated
the gene telomeric to D6S411, D6S1550, and D6S1579,
which are at the same locus, and demonstrated that
D6S305, which also mapped to the same locus, is telo-
meric to these three markers. More-centromeric recom-
bination events, observed with marker D6S419, in pa-
tients from families DEL-001 (individual 14) and
IT-2-021 (individual 5) confirmed this telomeric locali-
zation. A distal recombination event in patient 8 from
family IT-2-021 defined D6S1719 as the telomeric
boundary. This was confirmed by a more telomeric re-
combination event observed with marker D6S264 in pa-
tient 4 from family SAL-711. The candidate interval be-
tween markers D6S411/D6S1550/D6S1579 and marker
D6S1719 is ∼11.3 cM.
Homozygosity was observed in patients from two con-
sanguineous families, DEL-001 and LYO-119. In the for-
mer, the entire region was homozygous except for
marker D6S419, whereas in the latter the region of ho-
mozygosity was restricted to four markers (D6S1550,
D6S411, D6S305, and D6S1599). The lack of homo-
zygosity at locus D6S1579 and at more-proximal mark-
ers suggested recombination between this marker and
D6S1550, D6S411, and D6S305, at the same locus, and
showed that D6S1579 is centromeric to the three other
markers at the same locus. These data restricted the can-
didate interval to the 11.3-cM region between D6S1579
and D6S1719. Regions of homozygosity spanning 2–7
markers were found in families SAL-711, IT-1-005, IT-
1-006, and IT-2-021, which originate from regions in
rural Portugal and Italy, and may result from undocu-
mented consanguinity. The haplotype of each family is
different, suggesting that the haplotypes derived from
independent ancestral mutations.
Characterization of Homozygous Deletion in
Family DEL-001
A single allele was detected with markers D6S411 and
D6S1550 in the mother and the unaffected sibs of family
DEL-001 (fig. 1). The three affected children received
no parental contribution at these loci, suggesting that
the disease segregated with a deletion, in this family.
Markers D6S305 and D6S1579, which colocalize on the
genetic map, were shown by recombination events to
represent the centromeric and the telomeric boundaries,
respectively. They were not included in the deletion. The
deletion therefore is located in a !1-cM interval flanked
by these markers. Two additional microsatellite markers
(AFMA155TD9 and AFMB281WF1) and one sequence-
tagged site (STS; WI4940) that map to the region, but
not the SOD2 gene, were found by PCR analysis to be
within the deletion. The existence of the deletion was
confirmed by Southern blot hybridization with the STS
in the three affected sibs (data not shown). Deletions of
the microsatellite markers or of STS WI4940 were not
detected in the other linked families.
Phenotype-Genotype Correlations
Evidence in favor of linkage was found in eight fam-
ilies of different geographical origins. The characteristics
of 23 patients from the chromosome 6–linked families
were compared with those of the 17 Japanese patients
with AR-JP reported elsewhere (Matsumine et al. 1997)
and the 7 patients from the three families in this study
that did not show evidence of linkage to chromosome
6q (table 3). The mean age at onset was years,35 11
Figure 1 Simplified pedigrees of the eight families showing linkage to the PARK2 locus, with haplotypes for nine chromosome 6q markers.
Blackened squares (men) and circles (women) represent affected individuals. Age at onset (in years) is indicated above the patient’s symbol.
Haplotypes were reconstructed to minimize the number of recombination events in each family. Genetic distances are indicated in centimorgans,
and markers are listed top to bottom from centromere to telomere. The order of D6S411 and D6S1550 at the same locus was defined arbitrarily.
Alleles are numbered as in the GDB. Haplotypes segregating with the disease are boxed. Reconstructed genotypes are within brackets. Note
that when both parents were not genotyped their haplotypes were assigned arbitrarily. A hyphen (-) indicates a deleted marker. ND  not
determined.
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Table 3
Clinical Comparison among Patients with Autosomal Recessive Early-Onset Parkinsonism Linked to Chromosome 6q, from
Europe and Algeria and from Japan, and Patients with Early-Onset PD Not Linked to Chromosome 6q
Early-Onset PD Linked
to Chromosome 6,
Present Study
(23 Patients, 8 Families)
Early-Onset PD Not
Linked to Chromosome 6q
(7 Patients, 3 Families)
Japanese AR-JP
(17 Patients, 12
Families)a
No. of men:no. of women 12:11 2:5 5:12
Mean (range) age at onset [years] 35  11 (7–58)∗ 36  10 (21–52) 28  9 (9–43)
Mean (range) disease duration [years] 15  7 (3–29)∗ 22  10 (4–36) 23  11 (7–52)
Hoehn and Yahr score 2.6  1 2.7  .8 2.7  .9
Percentage of patients with:b
Bradykinesia 97 (22/23) 100 (7/7) 76 (13/17)
Rigidity 97 (22/23) 100 (7/7) 71 (12/17)
Tremor 83 (19/23) 57 (4/7) 94 (16/17)
Response to levodopa Good 71 (15/21)
Excellent 29 (6/21)
Good 3/7
Excellent 4/7
Satisfactory 100 (17/17)
Diurnal fluctuations of
levodopa response
63 (10/16) 100 (4/4) 87 (13/15)
Dopa-induced dyskinesias 73 (16/22) 57 (4/7) 93 (14/15)
Other symptomsb Dystonia (5/11)
Brisk reflexes (4/16)∗
Axonal neuropathy (1/16)
Painful dystonia (3/16)
Dystonia (2/3) Dystonia (10/16)
Brisk reflexes (14/17)
Retropulsion (15/17)
a From Ishikawa and Tsuji (1996).
b The number of patients for whom specific information was available is indicated in parentheses.
∗ , for comparison between the families with early-onset PD linked to chromosome 6 and the Japanese AR-JP families.P ! .05
with a range of 7–58 years, in the chromosome 6–linked
families, which is significantly older than that in the
Japanese families ( ; ). The overall clinical28 9 P ! .05
picture was a mild to moderate parkinsonian syndrome
that responded well to levodopa, with the appearance
of dyskinesias in 73% of the patients, after a mean dis-
ease duration of years. Signs at onset were one15 7
or two of the parkinsonian triad ( ), dystonia inn  21
the foot ( ), and difficulty walking ( ). Impas-n  1 n  1
sive face was frequent (7/8 patients). Scores on the Mini
Mental State (MMS) examination were normal (x25/
30) for 20 patients. For three patients, abnormal MMS
scores of 15, 20, and 24, after disease durations of 17,
12, and 27 years, respectively, were seen. Brisk reflexes
were present in 4/16 patients, which is significantly less
than the number of Japanese patients (14/17; )P ! .05
with brisk reflexes. Additional signs were painful dys-
tonia in three patients from two families (DEL-001 and
SAL-711) and pronounced anxiety, requiring treatment,
in eight patients.
Discussion
We have identified eight families with a high posterior
probability of linkage to the PARK2 locus on chromo-
some 6, determined from two-point LOD scores for
marker D6S305, which maps to the same genetic locus
as the disease. The high proportion of families (7/10)
that present with evidence of linkage indicates that the
AR-JP locus is a common locus for early-onset Parkin-
sonism in Europeans. The clinical features of AR-JP in
patients from the European and Algerian families stud-
ied could not be distinguished from those in patients
from families that did not show linkage to chromosome
6 and were, for the most part, similar to those in patients
from Japanese families (Yamamura et al. 1973; Taka-
hashi et al. 1994; Ishikawa and Tsuji 1996)—namely,
early onset in some family members, marked and sus-
tained response to low doses of levodopa, early ap-
pearance of dyskinesia, and slow disease progression.
However, the clinical spectrum of the disease was larger
and the phenotype corresponded better to the clinical
definition of early-onset PD than did the juvenile form
(Quinn et al. 1987). Age at onset, which did not exceed
43 years in Japanese families (Yamamura et al. 1973;
Takahashi et al. 1994; Ishikawa and Tsuji 1996), was
150 years for several of our patients, with 58 years being
the oldest. Sleep benefit was not a prominent feature,
and dystonia was rare in our families. However, painful
dystonia, which has not been reported previously for
AR-JP, was observed in two families, including DEL-
001, which has a homozygous deletion; this symptom
might result from complete loss of function because of
the deletion. This also may explain why age at onset
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was markedly earlier in patients from family DEL-001
(mean years) than in those without detectable13 6
deletions (mean years; ). Alternatively,38 8 P ! .01
painful dystonia in family DEL-001 could result from
the deletion or disruption of a contiguous gene (contig-
uous-gene syndrome). Since autopsies were not per-
formed on patients from the eight families that showed
linkage to the PARK2 locus, we cannot confirm that
Lewy bodies are absent in this disease (Yamamura et al.
1993; Takahashi et al. 1994).
With the assumption that the deletion in family DEL-
001 encompasses the gene responsible for AR-JP, this
study of eight families enabled us to reduce the candidate
interval from 17 cM between markers D6S437 and
D6S264 (Matsumine et al. 1997) to !1 cM between
markers D6S411/D6S1550 and microsatellite D6S305.
Recombination events reduced the candidate interval to
an 11.3-cM region between the locus defined by markers
D6S411/D6S1550/D6S1579 and marker D6S1719. The
minimal region of homozygosity in two consanguineous
families (DEL-001 and LYO-119) defined markers
D6S1579 and D6S1719 as the centromeric and the telo-
meric boundaries of the candidate interval, which was
restricted further, by a deletion in family DEL-001, to a
small region containing D6S411 and D6S1550 and
flanked by D6S1579 and D6S305, which colocalize on
the genetic map. This deletion also contains one STS and
two other microsatellite markers. Although its physical
size has not yet been determined, it is probably small.
Two of the several markers that colocalize on the genetic
map were not deleted. Several expressed sequence tags
have been identified in the PARK2 region, but none have
been mapped to the !1-cM candidate interval. Our re-
sults are in good agreement with those of Saito et al.
(1998), who restricted the candidate interval to the 13-
cM region flanked by D6S1579 and D6S264 and sug-
gested, on the basis of linkage-desequilibrium studies,
that the AR-JP gene most likely is located near the 4-
cM interval between D6S1579 and D6S1599. Interest-
ingly, the small deletion detected in family DEL-001 is
contained within their proposed 4-cM interval.
In conclusion, we have shown that AR-JP is not re-
stricted to Japan and that the AR-JP locus represents a
common locus for early-onset PD in European and Al-
gerian patients. The clinical features in the European and
Algerian families are indistinguishable from those of
early-onset idiopathic PD, and the clinical spectrum is
larger than that reported in Japan. The latter could be
explained by allelic heterogeneity. This hypothesis is sup-
ported by the observation of different haplotypes among
families, suggesting the occurrence of independent an-
cestral mutations. The Parkin gene at the PARK2 locus
on chromosome 6 was identified very recently (Kitada
et al. 1998). We now are able to confirm that this gene
is also implicated in our families with AR-JP.
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